New vs. standard robotic prostate surgery for early cancer
Part of Cancer, Kidney & urinary clinical trials.
This study compares two ways of doing robot‑assisted prostate removal surgery. It aims to see if a newer, less invasive method through a single small cut is as safe and effective as the standard method. If you have early‑stage prostate cancer and are eligible, you could help improve surgical recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 75 years old.
- Your prostate cancer has not spread outside the prostate (stage T1c to T2b, N0, M0).
- Your Gleason score is less than 8 and PSA level is under 20 ng/mL.
- You have a common type of prostate cancer (adenocarcinoma) and are able to have intercourse both before and after surgery.
- You are in good enough health for a laparoscopic surgery and can fill out questionnaires in Chinese.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a combined PSMA-PET/MRI and ultrasound navigation system during robot-assisted prostate removal can help the surgeon remove the cancer more completely while preserving surrounding tissue. It is for patients with early-stage prostate cancer that is just starting to spread outside the prostate.
This trial compares two nerve-sparing surgery techniques for prostate cancer to see which one better protects urinary control and sexual function while still removing the cancer. It may help men with early-stage prostate cancer who are planning to have robotic surgery.
This trial compares a new robotic surgical technique (with a special urethra repair) to standard robotic surgery and laparoscopic surgery for men with newly diagnosed prostate cancer that has not spread. The goal is to see which approach best preserves urinary control.
This study compares two types of robot-assisted surgery for treating prostate or kidney cancer. It aims to see if a single-port approach (through one small incision) is as safe and effective as the standard multi-port approach (through several small incisions), potentially offering faster recovery and less pain.
This trial is testing whether robot-assisted surgery can be a safe and effective way to treat early-stage prostate or kidney cancer. If you are eligible, it could give you access to a less invasive surgical option.
This study looks at a robotic prostate operation that aims to remove only the affected side while keeping the urethra (the tube for urination) to help preserve urinary function. It’s for people with low- to intermediate-risk, one-sided prostate cancer and no spread to lymph nodes, bones, or other organs.
Hear when a new Prostate Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.